We also investigated the potential associations of LRRC3B polymorphisms with clinicopathological characteristics of BC, including tumor size, lymph node metastasis, clinical stage, the status of ER, PR, Her-2, and Ki67 (Table 4). This evidence concerns the gene LRRC3B and neoplasm.